Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of antimicrobial agents
- Publicado em
- 7 mai 2023
- Citações
- 12
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials
Tim Yi-Ting Chen, Chi-Kuei Hsu, Shun-Chuan Shih, Teng-Song Weng, Hung-Jen Tang, Chih-Cheng Lai
Descritores MeSH
- Intraabdominal Infections
- Anti-Bacterial Agents
- Cephalosporins
- Drug Combinations
- Humans
- Tetracyclines
- Carbapenems
- Randomized Controlled Trials as Topic
- Azabicyclo Compounds
- Tazobactam
Veja também
Estudos relacionados
- Ceftazidime/avibactam and ceftolozane/tazobactam for severe paediatric infections: A systematic review, meta-analysis, and evidence map
- A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
- Comparison of ceftolozane-tazobactam and ceftazidime-avibactam for the treatment of infections caused by drug-resistant Pseudomonas aeruginosa: an updated systematic review and meta-analysis based on adjusted data from observational studies
- Ceftazidime-avibactam versus ceftolozane-tazobactam in the treatment of drug-resistant Pseudomonas aeruginosa: a meta-analysis